Resistance to endocrine therapy A panel discussion William L. McGuireMarc E. LippmanE. Brad Thompson Viewpoints Pages: 165 - 173
Steroid receptors in breast cancer: Sources of inter-laboratory variation in dextran-charcoal assays Susan M. Thorpe Methods review Pages: 175 - 189
Progesterone receptor activity and relapse-free survival in patients with primary breast cancer: The role of adjuvant chemotherapy J. M. M. RaemaekersL. V. A. M. BeexD. Wagener Report Pages: 191 - 199
Urinary androgens and tumor estrogen receptor as predictors of ovariectomy response and of survival in advanced breast cancer Saro OrianaGiorgio SecretoAndrea Torri Report Pages: 201 - 205
The DNA labelling index: A prognostic factor in node-negative breast cancer Michel HéryJeannine GioanniAdel Courdi Report Pages: 207 - 211
Meningeal carcinomatosis from breast cancer: Spinal cord vs. brain involvement Gerald ClamonBradley Doebbeling Report Pages: 213 - 217
Analysis of interval breast carcinomas in a randomized screening trial in Stockholm Jan FrisellGunnar EklundAnders Somell Report Pages: 219 - 225
Association between season of first detection of breast cancer and disease progression Barbara H. MasonIan M. HoldawayJacqueline Anderson Report Pages: 227 - 232